Mizuho reiterates Corteva stock rating on challenging crop market

Mizuho reiterated an Outperform rating and $16.00 price target for Corteva Inc. (CTVA) after its latest results. The stock is undervalued at $12.14, with a market cap of $8.1 billion. Corteva reported a 17% YoY decline in EBITDA, with regional sales varying. The company reduced its 2026 EBITDA guidance due to challenging market conditions, particularly in Brazil. Q3 results missed expectations, with revenue down 9% YoY.

Original reporting
Published Nov 12, 2026, 12:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 12:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CTVA
Bearish
medium confidence
Mentioned
$CTVA
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CTVABearishMed
01

Why it matters

The earnings miss and guidance reduction are likely to depress the stock in the short term, though regional sales growth in North America offers a counterpoint.

02

Market read

Corteva's weaker-than-expected results and lowered guidance are the primary drivers of relevance for traders.

03

What to watch

Potential upside from the 7% volume growth in North America and new product launches could mitigate the downside.

Relevance 7/10Novelty 7/10Timing: post‑market release

Background

Corteva reported Q3 results that missed consensus on EPS and revenue, and lowered its 2026 EBITDA guidance amid challenging market dynamics.

Company-level read

Ticker impact

$CTVABearishMedium confidence
Context

Mizuho reiterated an Outperform rating and cut 2026 EBITDA guidance to $1.1‑$1.125 B, citing weaker crop market conditions in Brazil.

Expected impact

likely pressure as the market prices in the lower EBITDA guidance and earnings miss

Evidence & confidence

The new guidance is materially lower than prior expectations and the earnings per share fell short of consensus, which typically triggers a sell‑off.

Market effects

Signals continued weakness in the crop protection sector, especially in Brazil.

May weigh on other agribusiness stocks exposed to Latin America.

Limited to agriculture‑related equities; no broad market effect expected.

Counterpoint

If the market overreacts to the guidance cut, a bounce could occur on any positive crop outlook news.

Key entities

  • Corteva Inc.

    U.S. agriscience firm providing crop protection products.

  • Mizuho

    Investment bank that reiterated an Outperform rating on Corteva.

Related articles

$CTVAHighAI 8/10

Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

Corteva, Inc. (CTVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook • Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds • Pricing pressure was concentrated in North America an

$CTVAHighAI 8/10

Corteva shares fall 6% on worse-than-expected Q3 results

Corteva Inc. (CTVA) reported Q3 earnings of $0.06 per share, missing estimates of $0.10, and revenue of $1.59B, below the $1.77B forecast. Shares fell 6.4%. Full-year 2026 guidance adjusted, with EPS midpoint at $0.78, above consensus, but EBITDA guidance lowered due to Brazil market conditions. Revenue declined 9% YoY, with Latin America sales down 31% and North America up 7%.

$CTVAHighAI 8/10

Why is Corteva stock sliding today?

Corteva stock fell 6.4% after reporting Q3 results below expectations, with net sales down 9% YoY and a GAAP loss of $54M. Adjusted EPS dropped 57% to $0.06. The company cited weak Latin America performance and revised 2026 guidance lower, citing Brazil market conditions. Analysts had already cut EPS estimates and price targets. The S&P 500 was flat, indicating the drop was company-specific.

$CTVAHighAI 8/10

Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

Corteva reported Q3 2026 results with net sales down 9% YoY to $1.59B, organic sales also down 9%. Adjusted EBITDA fell 17% to $222M. Full-year guidance was updated, reflecting weaker Brazil market conditions, with adjusted EBITDA now expected between $1.1B and $1.125B. CEO Luke Kissam cited strong new product performance and operational excellence.